NASDAQ Newsfeed

… stock in the tech-heavy Nasdaq-100 index last quarter wasn …

… into Acadia Healthcare Company, Inc. (NASDAQ: ACHC) for potential violations of …

… been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the …

… against Super Micro Computer, Inc. (NASDAQ: SMCI) and certain of the …

… filed against Extreme Networks, Inc. (NASDAQ: EXTR) and certain of the …

… &P 500 and the Nasdaq rose slightly on Friday, with … 5,725.41 and the Nasdaq Composite gained 131.94 points … -to-1 ratio on the Nasdaq. The S&P 500 … one new low, while the Nasdaq Composite recorded 77 new highs …

… the US bourse. The Nasdaq Composite The Nasdaq composite soared 1.2 … , The opening bell of the Nasdaq Composite rang at 18,130 …

Fintech startup SoFi Technologies (NASDAQ: SOFI) stock closed nearly 7. … -week high. SoFi Technologies, Inc. (NASDAQ: SOFI) is a financial technology …

… of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) resulting from allegations that …

… surges after tepid start in Nasdaq debut Close China's … surges after tepid start in Nasdaq debut Published On: Fri, 04 … a sluggish start to its Nasdaq debut. The company, which brands …

… NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology … of Directors, as required by Nasdaq Rule 5635(c)(4), and … to employment in accordance with Nasdaq Rule 5635(c)(4). About …

… NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using … with Cidara, in accordance with Nasdaq Listing Rule 5635(c)(4 … employment with Cidara, pursuant to Nasdaq Listing Rule 5635(c)(4 …

… today that The Nasdaq Stock Market LLC (“Nasdaq”) notified Urgently ( … the Compliance Period, unless Nasdaq exercises its discretion to … listing standards for The Nasdaq Capital Market (with … not ultimately meet applicable Nasdaq requirements after such relief, …

… (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused … Company received notice that the Nasdaq Hearings Panel (the “Panel”) had … stockholder’s equity requirement under Nasdaq Listing Rule 5550(b)(1 …

… , Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with … with Assertio in accordance with NASDAQ Listing Rule 5635(c)(4 …

… NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the … were approved in accordance with Nasdaq Listing Rule 5635(c)(4 …

… rising 341 points and the Nasdaq Composite up 219 points. Stocks …

… Altamira” or the “Company”) (Nasdaq:CYTO) today announced that it … Department of The Nasdaq Stock Market LLC (“Nasdaq”) that it … Altamira Therapeutics Altamira Therapeutics (Nasdaq: CYTO) is developing and … to remain listed on Nasdaq. Any forward-looking …

… ) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation … of common stock on the Nasdaq Global Select Market (“Closing … and, in accordance with Nasdaq Listing Rule 5635(c)(4 … Anika Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint …

… the Company in accordance with Nasdaq Listing Rule 5635(c)(4 … common stock as reported by Nasdaq on October 1, 2024. The … new employees in accordance with Nasdaq Listing Rule 5635(c)(4 … shares are listed on the Nasdaq Global Market (symbol "SMMT …

… NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or … ”) and in accordance with Nasdaq Listing Rule 5635(c)(4 … closing market price on the Nasdaq Stock Market of the … grant. About NewAmsterdam NewAmsterdam Pharma (Nasdaq: NAMS) is a late-stage …

… ) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage … common stock as reported by Nasdaq on October 1, 2024. … information in accordance with Nasdaq Listing Rule 5635(c … Arcutis Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a commercial-stage …

… -- Verb Technology Company, Inc. (Nasdaq: VERB) ("VERB" or … to trade on the Nasdaq Capital Market under the … Company into compliance with The Nasdaq Capital Market's …   Verb Technology Company, Inc. (NASDAQ: VERB), is the innovative force …

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical … the Company in accordance with Nasdaq Listing Rule 5635(c)(4 … into employment in accordance with Nasdaq Listing Rule 5635(c)(4 …

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T- … with Atara, in accordance with Nasdaq Listing Rule 5635(c)(4 … this information in accordance with Nasdaq Listing Rule 5635(c)(4 …